Chord Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • M&A

Chord Therapeutics General Information

Description

Operator of a pharmaceutical company intended to produce drugs to cure rare neurological diseases. The company is dedicated to repurposing the small molecule drug under orphan drug or orphan medicinal product designation, to bring a new effective therapy for patients with life-threatening and severely disabling neurological diseases, enabling patients suffering from rare diseases to change their lives.

Contact Information

Website
www.chordtherapeutics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Avenue de Sécheron 15
  • 1202 Geneva
  • Switzerland
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Acquirer
Merck
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Avenue de Sécheron 15
  • 1202 Geneva
  • Switzerland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Chord Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 31-Jan-2022 Completed Generating Revenue
3. Later Stage VC (Series A) 13-Oct-2020 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. Seed Round Completed Startup
To view Chord Therapeutics’s complete valuation and funding history, request access »

Chord Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pharmaceutical company intended to produce drugs to cure rare neurological diseases. The company is dedica
Pharmaceuticals
Geneva, Switzerland
3 As of 2021

Aarhus N, Denmark
 

Vancouver, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Chord Therapeutics Competitors (3)

One of Chord Therapeutics’s 3 competitors is NMD Pharma, a Venture Capital-Backed company based in Aarhus N, Denmark.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NMD Pharma Venture Capital-Backed Aarhus N, Denmark
Cytodyn Formerly Angel backed Vancouver, WA
AnTolRx Venture Capital-Backed Cambridge, MA
You’re viewing 3 of 3 competitors. Get the full list »

Chord Therapeutics Patents

  • 33

    Total Documents Applications and Grants

  • Total Patents Families

  • 20

    Granted

  • 8

    Pending

  • Expiring in next 12 mo

Chord Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202107075-D0 Cladribine regimen for treating nmosd Inactive 18-May-2021
GB-202019460-D0 Use of cladribine for treating immune brain disease Inactive 10-Dec-2020
GB-2601786-A Use of cladribine for treating immune brain disease Inactive 10-Dec-2020
AU-2021397864-A1 Use of cladribine for treating immune brain disease Pending 10-Dec-2020
CA-3200184-A1 Use of cladribine for treating immune brain disease Pending 10-Dec-2020 A61K31/7076
To view Chord Therapeutics’s complete patent history, request access »

Chord Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Chord Therapeutics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
EPFL Innovation Park Accelerator/Incubator Minority
Fondation Eclosion Accelerator/Incubator Minority
Omega Funds Venture Capital Minority
To view Chord Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Chord Therapeutics FAQs

  • When was Chord Therapeutics founded?

    Chord Therapeutics was founded in 2014.

  • Where is Chord Therapeutics headquartered?

    Chord Therapeutics is headquartered in Geneva, Switzerland.

  • What is the size of Chord Therapeutics?

    Chord Therapeutics has 3 total employees.

  • What industry is Chord Therapeutics in?

    Chord Therapeutics’s primary industry is Pharmaceuticals.

  • Is Chord Therapeutics a private or public company?

    Chord Therapeutics is a Private company.

  • What is Chord Therapeutics’s current revenue?

    The current revenue for Chord Therapeutics is .

  • How much funding has Chord Therapeutics raised over time?

    Chord Therapeutics has raised $16M.

  • Who are Chord Therapeutics’s investors?

    EPFL Innovation Park, Fondation Eclosion, and Omega Funds have invested in Chord Therapeutics.

  • Who are Chord Therapeutics’s competitors?

    NMD Pharma, Cytodyn, and AnTolRx are competitors of Chord Therapeutics.

  • When was Chord Therapeutics acquired?

    Chord Therapeutics was acquired on 31-Jan-2022.

  • Who acquired Chord Therapeutics?

    Chord Therapeutics was acquired by Merck.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »